Our Non-Hodgkin Lymphoma Program treats children with all forms of non-Hodgkin lymphoma and related disorders, including relapsed or hard-to-treat Hodgkin lymphoma. Staffed with some of the world's most experienced pediatric oncologists and pediatric subspecialists, we provide direct access to the newest clinical trials and advanced therapies.
Our Non-Hodgkin Lymphoma Program treats children with all forms of non-Hodgkin lymphoma [non-Hodgkin lymphoma condition page] and related disorders. If your child has relapsed or has hard-to-treat Hodgkin lymphoma, we provide direct access to the newest clinical trials and advanced therapies.
Through Dana-Farber/Boston Children's Cancer and Blood Disorders Center, your child will receive treatment from some of the world's most experienced pediatric oncologists at Dana-Farber Cancer Institute, as well as internationally recognized pediatric subspecialists at Boston Children's Hospital.
The Non-Hodgkin Lymphoma Program is a special part of our Pediatric Oncology Program.
All members of our team, which includes pediatric oncologists, radiation oncologists, surgeons, interventional and diagnostic radiologists and hematopathologists, have specific expertise in pediatric lymphomas.
We offer comprehensive diagnosis, treatment, and consultation services for children and adolescents.
We provide access to multiple clinical trials investigating new treatment approaches, as well as advanced therapies like stem cell transplantation.
Our center offers a long-term care program specially designed for survivors of childhood cancer.
Our Non-Hodgkin Lymphoma Program treats children with the following conditions:
The Non-Hodgkin Lymphoma Program is a part of our Pediatric Oncology Program. We combine the expertise of both Boston Children's Hospital, one of the top pediatric hospitals in the country, and Dana-Farber Cancer Institute, a national leader in cancer care.
Members of our physician team all have expertise in pediatric lymphomas. Specific disciplines include:
We evaluate, diagnose and treat children with all forms of non-Hodgkin lymphoma and related disorders. We also provide consultation services and long-term follow-up for pediatric and adolescent patients.
If your child has been diagnosed with non-Hodgkin lymphoma, you probably have a lot of questions about treatment and care options. Our program offers the latest treatments for non-Hodgkin lymphoma and our researchers work continuously to develop and refine therapies. We offer:
Other services include:
Like all patients who were treated with chemotherapy and/or radiation, survivors of childhood non-Hodgkin lymphoma may be at risk of developing problems or side effects later in life.
To help patients monitor their overall health after they're finished with treatment, we encourage children and adolescents to continue long-term care through Dana-Farber's David B. Perini Jr. Quality of Life Clinic. At this clinic, experts assess childhood cancer survivors of all ages for hormonal evaluation and treatment and dental evaluation and treatment, among others.
The Non-Hodgkin Lymphoma Program has a staff of compassionate and experienced pediatric specialists that includes oncologists, radiation oncologists, radiologists, surgeons, and stem cell transplant experts.
Our physicians are focused on family-centered care: From your first visit, you'll work with a team of professionals who are committed to supporting all of your family's physical and psychosocial needs.
It's possible that your child will be eligible to participate in one of Dana-Farber/Boston Children's current clinical trials. These studies are useful for many reasons. Some trials are designed to evaluate the effectiveness of a particular drug, treatment or therapy on a specific disease; others help doctors to better understand how and why certain conditions occur.
Participation in any clinical trial is completely voluntary: We will take care to fully explain all elements of the treatment plan prior to the start of the trial, and you may remove your child from the medical study at any time.
Dana-Farber/Boston Children's is a part of the Children's Oncology Group, a national cancer research consortium. Children's Oncology Group studies include:
Referring physicians: 617-632-5508 or 1-888-Pedi-Onc (733-4662)
We understand a diagnosis of non-Hodgkin lymphoma is extremely difficult to cope with. We are available to offer a consultation or second opinion for your child.
If your child has been diagnosed with non-Hodgkin lymphoma, please contact our program at 888-PEDI-ONC (888-733-4662).
To help us conduct a precise evaluation, it is important we receive a full summary of your child's initial diagnosis at hand. This includes any laboratory or pathology reports, any x-ray, radiographic or MRI images, as well as a list of any previous treatments your child may have received. We will work with you and any other treating physicians to obtain the necessary information prior to the visit, including:
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02115
Boston Children's Hospital300 Longwood AvenueBoston, MA 02215
Browse clinical trials
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: